Bowel Management Systems - Market Insights, Competitive Landscape, and Market Forecast - 2030

Bowel Management Systems - Market Insights, Competitive Landscape, and Market Forecast - 2030

Bowel Management Systems Market by Product Type (Devices [Irrigation Systems, Nerve Modulation Devices, and Others], and Accessories), Patient Type (Adult and Pediatrics), End-User (Hospitals, Ambulatory Surgical Centres, and Homecare), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing prevalence of neurological disorders and growing product developmental activities worldwide

The bowel management systems market was valued at USD 1.42 billion in 2023, growing at a CAGR of 3.98% during the forecast period from 2024 to 2030, in order to reach USD 1.78 billion by 2030. The bowel management systems market is expanding rapidly due to the increasing prevalence of neurological disorders including multiple sclerosis, growing product developmental activities, increasing instances of spinal cord injuries, and others that are expected to escalate the overall growth of the bowel management systems market during the forecast period from 2024 to 2030.

Bowel Management Systems Market Dynamics:

According to the World Health Organization (WHO) (2024) in 2021, 15.4 million people were living with spinal cord injuries globally. Most cases of spinal cord injury result from trauma, including falls, or acts of violence, and are therefore preventable.

As per data from the WHO (2023), it was reported that over 1.8 million people worldwide are affected by Multiple sclerosis (MS). It impacts various functions including cognitive, emotional, motor, sensory, and visual abilities. It occurs when the immune system mistakenly attacks the brain and spinal cord.

Bowel management systems play a crucial role in the care of individuals with spinal cord injuries and multiple sclerosis, as both conditions can lead to significant bowel dysfunction. For those with spinal cord injuries, bowel management systems help facilitate regular bowel movements and prevent complications such as fecal incontinence, enhancing overall quality of life. Similarly, patients with multiple sclerosis often experience challenges in bowel control due to neurological impairments. Implementing effective bowel management systems allows for better regulation of bowel function, minimizing discomfort and promoting independence for individuals affected by these conditions.

Rising product developmental activities such as product launches by the market key player are also contributing in increasing revenue shares for the same. For example, in February 2024, Coloplast launched Peristeen® Light, a new transanal irrigation device designed to assist individuals with bowel disorders, specifically those dealing with defecation issues or stool leakage.

Therefore, the factors stated above collectively will drive the overall bowel management systems market growth.

However, side-effects such as infections, skin irritation, and bowel perforation, among others, availability of alternative options, and others may prove to be challenging factors for bowel management systems market growth.

Bowel Management Systems Market Segment Analysis:

Bowel Management Systems Market by Product Type (Devices [Irrigation Systems, Nerve Modulation Devices, and Others], and Accessories), Patient Type (Adult and Pediatrics), End-User (Hospitals, Ambulatory Surgical Centres, and Homecare), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the bowel management systems market, the nerve modulation devices sub-category is expected to have a significant revenue share in the year 2023. This is because of the widespread uses and features of nerve modulation devices that enhance their utility and effectiveness.

Nerve modulation devices for bowel management systems utilize electrical stimulation to regulate bowel function, offering a non-invasive solution for individuals experiencing bowel dysfunction. These devices typically feature adjustable stimulation settings, allowing for personalized treatment tailored to the patient’s specific needs. They often include remote control or app-based interfaces for ease of use and monitoring.

In clinical applications, nerve modulation devices are effective in managing conditions such as fecal incontinence and constipation, particularly in patients with neurological disorders or injuries affecting bowel control. By stimulating the sacral nerves, these devices can enhance bowel motility, reduce the need for manual interventions, and improve overall bowel function, thereby significantly enhancing patients' quality of life.

Therefore the widespread uses and various features of nerve modulation devices enhance performance and usability, solidifying the significant impact on the growth of the overall bowel management systems market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall bowel management systems market:

Among all the regions, North America is expected to dominate the bowel management systems market in the year 2023 and is expected to do the same during the forecast period. This is driven by the growing burden of Parkinson’s disease, increasing regulatory approval, the presence of well-established healthcare infrastructure, and others, acting as key factors contributing to the growth of the bowel management systems market in the North America region during the forecast period from 2024 to 2030.

Parkinson's Foundation in 2024 stated that, currently near about one million people in the U.S. are living with Parkinson's disease. This number is projected to increase to 1.2 million by 2030. Parkinson's disease is the second-most common neurodegenerative disorder, following Alzheimer's disease. Each year, approximately 90,000 new cases of Parkinson's are diagnosed in the US.

Bowel management systems are essential for individuals with Parkinson's disease, as the condition frequently causes gastrointestinal issues like constipation and fecal incontinence. These systems assist in effective bowel irrigation and evacuation, helping patients maintain dignity and quality of life. As the disease progresses, tailored bowel management becomes critical, enabling patients and caregivers to address bowel dysfunction challenges. Integrating these systems into care plans supports better gastrointestinal health and overall well-being for those affected by Parkinson's disease.

Rising product developmental activities by regulatory bodies in the region will further boost the market for bowel management systems. For example, in February 2022, Medtronic received the USFDA approval for the InterStim X™ system, the next generation of the most personalized sacral nerve stimulation therapy for bladder and bowel control.

Therefore, the interplay of all the aforementioned factors would provide a conducive growth environment for the North American bowel management systems market.

Bowel Management Systems Market key players:

Some of the key market players operating in the bowel management systems market include Coloplast Pty Ltd, Medtronic, ConvaTec Inc., Hollister Incorporated, B. Braun Melsungen AG, 3M, Cardinal Health., BD, Dentsply Sirona, Norgine, Attends Healthcare, Products, Inc., Teleflex Incorporated, Laborie, Consure Medical., Axonics, Inc., Renew Medical Inc, and others.

Recent Developmental Activities in the Bowel Management Systems Market:

• In November 2021, Medtronic announced that the U.S. Food and Drug Administration, granted 510(k) clearance for its PillCam™ Small Bowel 3 system, intended for remote endoscopy procedures.
• In October 2021, Laborie, acquired Pelvalon, Inc., a privately-held medical device company that developed an innovative product Eclipse™ System, a non-surgical, patient-controlled device for women suffering from faecal incontinence.
• In May 2021, Axonics, Inc., a global medical technology company focused on developing and commercializing novel products for the treatment of bladder and bowel dysfunction, received European CE Mark approval for its second-generation Axonics r-SNM® implantable neurostimulator (INS) and wireless patient remote control with SmartMRI™ technology.

Key Takeaways from the Bowel Management Systems Market Report Study

• Market size analysis for current bowel management systems market size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the bowel management systems market.
• Various opportunities available for the other competitors in the bowel management systems market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current bowel management systems market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for bowel management systems market growth in the coming future?

Target Audience who can be benefited from this Bowel Management Systems Market Report Study

• Bowel management systems product providers
• Research organizations and consulting companies
• Bowel management systems-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in bowel management systems
• Various end-users who want to know more about the bowel management systems market and the latest technological developments in the bowel management systems market

Frequently Asked Questions for the Bowel Management Systems Market:

1. What are Bowel Management Systems?

The bowel incontinence, also known as faecal incontinence is generally the situation when the patient is not able to control bowel movements which results in involuntary loss of solid or liquid stool. The clinical devices used to manage bowel activity are called bowel management systems.

2. What is the market for Bowel Management Systems?

The bowel management systems market was valued at USD 1.42 billion in 2023, growing at a CAGR of 3.98% during the forecast period from 2024 to 2030, to reach USD 1.78 billion by 2030.

3. What are the drivers for the Bowel Management Systems market?

The bowel management systems market is expanding rapidly due to the increasing prevalence of neurological disorders including multiple sclerosis, growing product developmental activities, increasing instances of spinal cord injuries, and others that are expected to escalate the overall growth of the bowel management systems market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the Bowel Management Systems market?

Some of the key market players operating in bowel management systems include Coloplast Pty Ltd, Medtronic, ConvaTec Inc., Hollister Incorporated, B. Braun Melsungen AG, 3M, Cardinal Health., BD, Dentsply Sirona, Norgine, Attends Healthcare, Products, Inc., Teleflex Incorporated, Laborie, Consure Medical., Axonics, Inc., Renew Medical Inc, and others.

5. Which region has the highest share in the Bowel Management Systems market?

Among all the regions, North America is expected to dominate the bowel management systems market in the year 2023 and is expected to do the same during the forecast period. This is driven by the growing burden of Parkinson’s disease, increasing regulatory approval, the presence of well-established healthcare infrastructure, and others, acting as key factors contributing to the growth of the bowel management systems market in the North America region during the forecast period from 2024 to 2030.